Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

This publication has 54 references indexed in Scilit:

• Re: Reversal of Relation Between Body Mass and Endogenous Estrogen Concentrations With Menopausal Status
  JNCI Journal of the National Cancer Institute, 1997
• Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies
  Published by Elsevier ,1996
• Oral contraceptives, menopausal estrogens, and the risk of breast cancer: A case‐control study in greece
  International Journal of Cancer, 1995
• Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States)
  Cancer Causes & Control, 1994
• Floating absolute risk: An alternative to relative risk in survival and case‐control analysis avoiding an arbitrary reference group
  Statistics in Medicine, 1991
• The Risk of Breast Cancer after Estrogen and Estrogen–Progestin Replacement
  New England Journal of Medicine, 1989
• Influence of non‐contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark
  International Journal of Cancer, 1988
• The relationship between blood prolactin levels and risk of breast cancer in premenopausal women
  European Journal of Cancer and Clinical Oncology, 1987
• Menopausal estrogen use and the risk of breast cancer
  Breast Cancer Research and Treatment, 1986
• An epidemiologic study of breast cancer and benign breast neoplasias in relation to the oral contraceptive and estrogen use
  Published by Elsevier ,1979